| Description | Ozanezumab (GSK1223249) is a monoclonal antibody targeting Nogo-A (neurite outgrowth inhibitor A). It is utilized in research related to amyotrophic lateral sclerosis (ALS) and multiple sclerosis [1]. |
| Synonyms | GSK1223249 |
| molecular weight | N/A |
| CAS | 1310680-64-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |